Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells.
about
Subcutaneous adipocytes promote melanoma cell growth by activating the Akt signaling pathway: role of palmitic acidn-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer.Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cellsDNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontinCuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondriaDietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.Diet, nutrients, phytochemicals, and cancer metastasis suppressor genes.The obesity-inflammation-eicosanoid axis in breast cancer.In obese mice exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.Hair cycle control by leptin as a new anagen inducer.Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob/ob obese mice.Obesity and melanoma: could fat be fueling malignancy?Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: role of adipokines.Role of BMI and hormone therapy in melanoma risk: a case-control study.Increment of subcutaneous adipose tissue is associated with decrease of elastic fibres in the dermal layer.Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state.
P2860
Q34431003-ECF93A6E-2D61-48DC-BF47-259A31E71788Q34577978-B19CF841-7FD3-4F69-8B4F-9DDCC1012821Q36213662-A21CEAB8-DA6F-4CA2-A698-F47A1D41340EQ37029660-11037A1A-CF9C-4634-BAAB-0ED158952EB4Q37148313-98AD07C8-5CD5-4BB0-9EBB-36167F8ADA88Q37293711-E6CB0BBF-ECA9-4495-9F61-F75D4EC68B28Q38018255-C2CAD7E3-45EE-4EC6-B0CF-3F49831D72EAQ38156366-2023AA80-45FF-4CD8-ACF3-1320B3E37E0CQ38287856-FE285DF4-BED6-4457-BA86-997D48A4CF63Q38311195-CB7783FE-98B9-49EB-BD81-70FCAFA2CDCCQ38325978-DA7E9174-AEC7-473B-8C9B-424F9B9E6985Q38754906-481B14F4-BBA2-4442-9E82-1E6FB8103F29Q38929602-DDDD38E6-8EC5-4DDE-8530-73AC013D3DD3Q40294088-D338BD27-7CEE-48E3-AE84-2E98146D7321Q42824915-2DD525C4-9CCC-429A-BA12-AF12ACB4BD3BQ55158049-8DDCD04F-494D-4B3A-9D12-401C7BAA060C
P2860
Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells.
@en
type
label
Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells.
@en
prefLabel
Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells.
@en
P2860
P1476
Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells.
@en
P2093
Kyoko Kushiro
Nomelí P Núñez
P2860
P2888
P304
P356
10.1007/S10585-011-9418-4
P577
2011-08-31T00:00:00Z
P6179
1039402427